Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico

Authors

  • Karina Mercado Soberanes Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México.
  • Evangelina Camacho Frías Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México.
  • Leonardo Rodríguez Balandrán Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México.
  • Martha Elena Rodríguez Fermán Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México.
  • Nancy Mendoza Méndez Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México.
  • Benjamin Velasco-Bejarano Laboratorio Nacional de Prevención y Control del Dopaje, Comisión Nacional de Cultura Física y Deporte, Camino Sta. Teresa # 482, Col. Peña Pobre Delegación Tlalpan, Ciudad de México, C.P. 14060, México. Sección de Química Orgánica, Departamento de Ciencias Químicas Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Av. 1 de Mayo, S/N, Col. Sta. Ma. Las Torres, Cuautitlán Izcalli, Estado de México, C.P. 54740, México. http://orcid.org/0000-0002-2934-8698

DOI:

https://doi.org/10.20882/adicciones.1012

Keywords:

Anti-Doping Control, Banned substances, National Antidoping Laboratory-CONADE, ISO/IEC-17025.

Abstract

The use of banned substances to increase athletes’ performance has been a scourge in international sport. In this sense, the World Anti-Doping Agency (WADA-AMA) has implemented a series of standards that harmonize the fight against doping. In particular, accredited WADA-AMA laboratories play an important role in the eradication of sports doping. This report shows the data obtained in the National Laboratory of Prevention and Control of Doping (LNPCD-CONADE) according to the incidence of Adverse Analytical Findings (AAF) in the 2009-2015 interval, which were obtained from the analysis of a total of 18,085 biological doping-control samples. The distribution of samples was analyzed as a function of gender, type of sport either in competition or out of competition, as well as the prevalence of AAF during the period of time analyzed and the relation regarding group of doping substance and type of sport. The data presented here were compared with those reported worldwide by the WADA-AMA and it was observed that in the cases of substances of the S1 group, the percentage reported by the LNPCD-CONADE is higher than the one reported worldwide. The opposite was observed for AAF presented by some substance from Groups S6 and S8. Likewise, a higher prevalence in the use of doping substances by male athletes (75%) is observed compared to that observed in female athletes (25%). The sports with the highest number of AAF detected in the laboratory were baseball, cycling, and athletics.

References

Aguilar, M., Muñoz-Guerra, J., Plata, M. M. & Del Coso, J. (2017). Thirteen years of the fight against doping in figures. Drug Testing and Analysis, 9, 866-869. doi:10.1002/dta.2168.

Arnedo, M., Ricarte, J., Martínez, S. & Salvador, A. (1998). Efectos de los esteroides anabolizantes-androgenizantes sobre diversas variables implicadas en el rendimiento deportivo. Revista de Psicología del Deporte, 7, 215-231.

Atienza, E., López, F. & Pérez, L. (2014). El Dopaje y el antidopaje en perspectiva histórica. Materiales para la Historia del Deporte, 12, 94-110.

Avella, R. & Medellín, J. (2012). Los esteroides anabolizantes androgénicos, riesgos y consecuencias. Revista U.D.C.A. Actualidad & Divulgación Científica, 15 (Supl. Olimpismo), 47-55.

Barroso, O., Godreault, D., Carbó, M., Ayotte, C., Mazzoni, I., Boghosian, T. & Rabin, O. (2012). Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sports. Drug Testing and Analysis, 4, 320-329. doi:10.1002/dta.291.

Beuck, S., Sigmund, G., Kock, A., Schänzer, W., Pokrywka, A., Kiatkowska, D. & Thevis, M. (2012). Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry. Drug Testing and Analysis, 4, 701-716. doi:10.1002/dta.1388.

Botrè, F., De la Torre, X. & Mazzarino, M. (2016). Multianalyte LC-MS-based methods in doping control: what are the implications for doping athletes? Bioanalysis, 8, 1129-1132. doi:10.4155/bio-2016-0083.

Brunton, L., Chabner, B. & Knollman, B. (2012). Goodman & Gilman Las Bases Farmacológicas de la Terapéutica. China: MC. Graw Hill.

Cadwallader, A., De la Torre, X., Tieri, A. & Botrè, F. (2010). The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. British Journal of Pharmacology, 161, 1-16. doi:10.1111/j.1476-5381.2010.00789.x.

Castaneto, M., Scheidweiler, K., Gandhi, A., Wohlfarth, A., Klette, K., Martin, T. & Huestis, M. (2015). Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Drug Testing and Analysis, 7, 483-493. doi:10.1002/dta.1709.

Catlin, D., Fitch. K. y Ljungqvist, A. (2008). Medicine and science in the fight against doping in sport. Journal of Internal Medicine, 264, 99-114. doi:10.1111/j.1365-2796.2008.01993.x.

Chebbah, C., Pozo, O., Deventer, K., Van Eenoo, P. & Delbeke, F. (2010). Direct quantification of 11-nor-D9-tetrahydrocannabinol-9-carboxilic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. Rapid Communications in Mass Spectrometry, 24, 1133-1141. doi:10.1002/rcm.4499.

Delgadillo, M., Garrostas, L., Pozo, O., Ventura, R., Velasco-Bejarano, B., Segura, J. & Marcos, J. (2012). Sensitive and robust method for anabolic agents in human urine by gas chromatography-triple quadrupole mass spectrometry. Journal of Chromatography B, 897, 85-89. doi:10.1016/j.jchromb.2012.03.037.

Deventer, K., Van Eenoo, P., Baele, G., Pozo, O., Van Thuyene, W. & Delbeke, F. (2009). Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. Drug Testing and Analysis, 1, 209-213. doi:10.1002/dta.31.

Donike, M. (2011). The detection of doping by means of chromatographic methods. Drug Testing and Analysis, 3, 15-17. doi:10.1002/dta.238.

DOF, Diario Oficial de la Federación, Órgano del Gobierno Constitucional de los Estados Unidos Mexicanos, Tomo DCXLV (14), 20 de junio de 2007, primera sección, 5-25.

DOF, Diario Oficial de la Federación, Órgano del Gobierno Constitucional de los Estados Unidos Mexicanos, Tomo DCLVII (10), 13 de junio de 2008, primera sección, 33-35.

Dvorak, J., Saugy, M. & Pitsiladis, Y. (2014). Challenges and threats to implementing the fight against doping in sports. British Journal Sports Medicine, 48, 807-809. doi:10.1136/bjsports-2014-093589.

González-Martí, I., Fernández-Bustos, J. G., Contreras, O. R., & Sokolova, M. (2017). Muscle dysmorphia: detection of the use-abuse of anabolic androgenic steroids in a Spanish sample. Adicciones. Advance publication online. doi:10.20882/adicciones.853.

Guddat, S., Fußhöller, H., Geyer, H., Thomas, A., Braun, H., Haenelt, N.,… Shänzer W. (2012). Clenbuterol-regional food contamination a possible source for inadvertent doping in sports. Drug Testing and Analysis, 4, 534-538. doi:101002/dta.1330.

Hemmersbach, P. (2008). History of mass spectrometry at the Olympic Games. Journal of Mass Spectrometry, 43, 839-853. doi:10.1002/jms.1445.

Instituto Mexicano de Normalización y Certificación, (IMNC) México (2006) NMX-EC-17025:IMNC:2006“Requisitos generales para la competencia de los laboratorios de ensayo y calibración”.

Kickman, A. & Cowan, D. (2009). Subject-based profiling for the detection of testosterone administration in sport. Drug Testing and Analysis, 1, 22-24. doi:10.1002/dta.14.

Kioukia, N., Fragkaki, A., Polyxeni, K., Pelagio, I., Dimopoulou, H., Tsivou, M.,… Georgakopoulos, C. (2014). A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece. Journal of Analytical Toxicology, 38, 16-23. doi:10.1093/jat/bkt089.

Koehler, K., Braun, H., De Marees, M., Geyer, H., Thevis, M., Mester, J. & Schaenzer, W. (2011). Urinary excretion of exogenous glycerol administration at rest. Drug Testing and Analysis, 3, 877-882. doi:10.1002/dta.355.

Marclay, F., Grata, E., Perrenoud, L. & Saugy, M. (2011). A one-year monitoring of nicotine use in sport: Frontier between potential performance enhancement and addiction issues. Forensic Science International, 323, 73-84. doi:10.1016/j.forsciint.2011.05.026.

Mareck, U., Geyer, H., Opfermann, G., Thevis, M. & Schänzer, W. (2008). Factors influencing the steroid profile in doping control analysis. Journal of Mass Spectrometry, 43, 877-891. doi:10.1002/jms.1457.

Mareck, U., Haenelt, N., Geyer, H., Guddat, S., Kamber, M., Brenneisen, R.,… Schänzer, W. (2009). Temporal indication of cannabis use by means of THC glucuronide determination. Drug Testing and Analysis, 1, 505-510. doi:10.1002/dta.106.

Möller, I., Wintermeyer, A., Bender, K., Jübner, M., Thomas, A., Krug, O.,… Thevis, M. (2011). Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Testing and Analysis, 3, 609-620. doi:10.1002/dta.158.

Monfort, N., Martínez, L., Bergés, R., Segura, J. & Ventura, R. (2015). Screening method for stimulants in urine by UHPLC-MS/MS: identification of isomeric compounds. Drug Testing and Analysis, 7, 819-830. doi:10.1002/ dta.1776.

O’Byrne, P., Kavanagh, P., McNamara, S. & Stokes, S. (2013). Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system. Journal of Analytical Toxicology, 37, 64-73. doi:10.1093/jat/bks091.

Parr, M. K., Blokland, M. H., Liebetrau, F., Schmidt, A. H., Meijer, T., Stanic, M.,… Sterk, S. S. (2017). Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial – The potential of enantiomeric separation for doping control analysis. Food Additives Contaminants: Part A, 34, 525-535. doi:10.1080/19140049.2016.

Ramos, A. (1999). Lucha contra el dopaje como objetivo de salud. Adicciones, 11, 299-310. doi:10.20882/adicciones.11.4.

Saugy, M., Lundby, C. & Robinson, N. (2014). Monitoring of biological markers indicative of doping: the athlete biological passport. British Journal Sports Medicine, 48, 827-832. doi:10.1136/bjsports-2014-093512.

Smith, A. & Stewart, B. (2015). Why the war on drugs in sport will never be won. Harm Reduction Journal, 12, 1-6. doi:10.1186/s12954-015-0087-5.

Sottas, P., Robinson, N., Rabin, O. & Saugy, M. (2011). The athlete biological passport. Clinical Chemistry, 57, 969-976. doi:10.1373/clinchem.2011.162271.

Strano, S., Abate, M., Bragano, M. & Botrè, F. (2009). Consumo de sustancias estimulantes y drogas de abuso en el deporte: la experiencia italiana. Adicciones, 21, 239-242. doi:10.20882/adicciones.21.3.

Thevis, M., Geyer L., Geyer H., Guddat, S., Dvorak, J., Butch, A.,… Schänzer W. (2013). Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. Drug Testing and Analysis, 5, 372-376. doi:10.1002/dta.1471.

Thevis, M., Hemmersbach, P. Geyer, H. & Schänzer, W. (2009). Doping im Behindertensport. Medizinische Klinik, 104, 918-924. doi: 10.1007/s00063-009-1190-8.

Thevis, M., Kuuranne, T., Geyer, H. & Schänzer, W. (2017). Annual banned-substance review; analytical approaches in human sports drug testing. Drug Testing and Analysis, 9, 6-29. doi:10.1002/dta.2139.

Thevis, M., Thomas, A., Beuk, S., Butch, A., Dvorak, J. & Schänzer, W. (2013). Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing. Rapid Communications in Mass Spectrometry, 27, 507-512. doi:10.1002/rcm.6485.

Thörngren, J., Östervall, F. & Garle, M. (2008). A high-throughput multicomponents screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS. Journal of Mass Spectrometry, 43, 980-992. doi:10.1002/jms.1436.

Velasco-Bejarano, B., Bautista, J., Noguez, M. O., Camacho, E., Rodríguez, M. E. & Rodríguez, L. (2017). Resolution of R-(-) and S-(+)-enantiomers of clenbuterol in pharmaceutical preparations and black-market products using liquid chromatography-tandem mass spectrometry. Drug Testing and Analysis, 9, 1738-1743. doi:10.1002/dta.2294.

WADA-AMA, ISL, 2009, 2012, 2015. International Standard for Laboratories (ISL). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/isl_ june_2016.pdf.

WADA-AMA, PL, 2009, 2010, 2011, 2012, 2013, 2015. The World Anti-doping Code Prohibited List International Standard. Retrieved at https://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents.

WADA-AMA, WLS, 2009, 2011, 2012, 2013, 2014, 2015.

WADA Laboratory Statistics. Retrieved at https://www.wada-ama.org/en/resources/laboratories/anti-doping-testing-figures.

WADA-AMA, SCP, 2006. Sample Collection Personnel: Recruitment, Training, Accreditation and Re-Accreditation Guideline. Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/wada_guidelines_sample_collection_personnel_2014_v1.0_en.pdf.

WADA-AMA, TD-DL, 2010, 2012, 2013, 2014. The World Antidoping Code, WADA Technical Document, Decision Limits for the Confirmatory Quantification of Threshold Substances (DL). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/wada-td2017dl-v2-en_0.pdf.

WADA-AMA, TD-EAAS, 2004, 2014. The World Antidoping Code, WADA Technical Document, Endogenous Anabolic Androgenic Steroids Measurement and Reporting (EAAS). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/wada-td2016eaas-eaas-measurement-and-reporting-en.pdf.

WADA-AMA, TD-IRMS, 2014. The World Antidoping Code, WADA Technical Document, Detection of synthetic forms of endogenous anabolic androgenic steroids by GC-C-IRMS (IRMS). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/wada-td2016irms-detection_synthetic_forms_eaas_by_irms-en.pdf.

WADA-AMA, IDCR, 2010, 2013, 2015. The World Antidoping Code, WADA Technical Document, Minimum criteria for chromatographic-Mass spectrometric confirmation of the identity of analytes for doping control purposes (IDCR). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/td2015idcr_-_eng.pdf.

WADA-AMA, TD-MRPL, 2009, 2010, 2012, 2014, 2015. The World Antidoping Code, WADA Techincal Document, Minimum Required Performance Levels for Detection and Identification of Non-Threshold Substances (MRPL). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/td2018mrpl_v1_finaleng.pdf.

WADA-AMA, TD-2017NA, 2009, 2010, 2012, 2014, 2015. The World Antidoping Code, WADA Technical Document, Harmonization of analysis and reporting of 19-Norsteroids related to nandrolone (NA). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/wada-td2017na-en_0.pdf.

WADA-AMA, TD-EPO, 2009, 2013, 2014. The World Antidoping Code, WADA Technical Document, Harmonization of the Method for the Identification of Epoetin Alfa and Beta (EPO) and Darbepoetin Alfa (NESP) by IEF-Double Blotting and Chemiluminescent Detection (EPO). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/WADA-TD2014EPO-v1-Harmonization-of-Analysis-and-Reporting-of-ESAs-by-Electrophoretic-Techniques-EN.pdf. WADA-AMA, TD-LDOC, 2009. The World Antidoping Code, WADA Technical Document, Laboratory Documentation Packages (LDOC). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/td2017ldoc_v2_ en.pdf.

WADA-AMA, TD-ICOC, 2009. The World Antidoping Code, WADA Technical Document, Laboratory Internal Chain of Custody (ICOC). Retrieved at https://www.wada-ama.org/sites/default/files/resources/files/WADA_TD2009LCOC_Laboratory_Internal_Chain_Custody_EN.pdf.

WADA-AMA, TD-NAND, 2004. The World Antidoping Code, WADA Technical Document, Reporting Norandrosterone Fin dings (NAND). Retrieved at http://www.wada-ama.org.

World Anti-Doping Agency. Acerca de la WADA-AMA. Retrieved at https://www.wada-ama.org.

Downloads

Additional Files

Published

2018-07-20

Issue

Vol. 31 No. 3 (2019)

Section

Originals